S. Couraud

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, Alexander Drilon, Amélie Lusque et al. · Annals of Oncology · 2019 · 1.4K citations · Full text

Life Sciences, Immunology, Oncology +17

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 421 citations · Full text

Medicine, Immunology, Oncology +15

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002

S. Couraud, Felipe Vaca‐Paniagua, Stéphanie Villar et al. · Clinical Cancer Research · 2014 · 211 citations

Medicine, Molecular Genetics, Oncology +17

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar et al. · European Respiratory Journal · 2015 · 150 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations

Claire Tissot, S. Couraud, Ronan Tanguy et al. · Lung Cancer · 2015 · 135 citations

Medicine, Molecular Genetics, Oncology +16